Navigation Links
MDA Awards $1 Million to Tivorsan Pharmaceuticals for Accelerating Pivotal Pre-Clinical Work on TVN-102 as a Potential Muscular Dystrophy Treatment
Date:1/5/2012

TUCSON, Ariz. and PROVIDENCE, R.I., Jan. 5, 2012 /PRNewswire-USNewswire/ -- The Muscular Dystrophy Association (MDA) today announced it has awarded $1.0 million to Tivorsan Pharmaceuticals to help speed pre-clinical work vital to a filing of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a recombinant humanized form of biglycan as a potential muscular dystrophy treatment.  The new funding to the Providence-based biotechnology firm comes from MDA Venture Philanthropy (MVP), a part of MDA's translational research program.

The project being advanced by Tivorsan is focused on treating Duchenne muscular dystrophy (DMD) by up-regulating the utrophin protein that's been shown to provide some compensation for disease-causing dystrophin deficiency in animals with DMD-like muscular dystrophy.  The company's TVN-102 experimental drug is based on biglycan, a naturally occurring protein found on the membrane surrounding each muscle fiber.  In the standard mouse model of DMD, biglycan reduced muscle damage, reduced muscle degeneration and improved muscle function.

DMD is one of nine types of muscular dystrophy, a group of genetic, degenerative diseases primarily affecting voluntary muscles.  Caused by mutations in the gene that makes dystrophin, a protein that normally protects muscle cells and keeps them intact, DMD eventually weakens all voluntary muscles, and the heart and breathing muscles.  DMD affects 1 in 3,500 boys with an estimated patient population exceeding 50,000 worldwide.   

"We are delighted to have a productive collaboration with Dr. Justin Fallon's laboratory at Brown University to bring such a promising potential muscular dystrophy treatment to market," said Joel B. Braunste
'/>"/>

SOURCE Muscular Dystrophy Association
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Medical Korea Offers 2011 Awards to Top Medical Tourism Service Providers (Institutions)
2. Span Diagnostics Ltd. Hits Bulls eye at ET NOW-IndiaMART Leaders of Tomorrow Awards 2011
3. MDA Awards $750,000 to Help Summit Test New Drug Formulation in Phase 1 Clinical Trial of Potential Treatment for Duchenne Muscular Dystrophy
4. Digital Assent Wins Back-to-Back Spirit of Endeavor Awards, This Year for Top "Emerging Technology Company"
5. WuXi PharmaTech Presents the 2011 Life Science and Chemistry Awards
6. GHX Calls on Member Community to Nominate Healthcares Most Impactful Business Partners for GHXcellence Awards
7. The Food and Drug Law Institute to Present Distinguished Service and Leadership Awards to Andersen, Autor, Brady, Thirolf
8. BRAVE Awards Recipients Announced
9. Novation Awards ICU Medical, Inc. a New Contract to Supply Members With a Complete Line of Clinically-Preferred Critical Care Products
10. Occupy Oakland Business Fraud Verdict: Oakland Jury Awards $9 Million Against Multi-National Corporation for Business Fraud and Breach of Contract
11. Glenmark Wins Two Prestigious Global Recognitions at SCRIP Awards 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... health affects a man,s lifestyle, and if he wants to ... he should address any hearing loss he may be experiencing. ... Institute (BHI) is delivering to men around the country ... leads up to and includes Father,s Day. This year, National ... To help men address their hearing health ...
(Date:5/23/2013)... recently published clinical study conducted at TOPS Comprehensive Breast ... that 3D mammography (breast tomosynthesis) significantly reduces unnecessary recalls ... study, "Implementation of Breast Tomosynthesis in a Routine Screening ... Stephen L. Rose , MD, and published in ... Roentgenology (AJR). The AJR is the scientific journal ...
(Date:5/23/2013)... May 23, 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, ... companies, based on intellectual property developed and owned ... ,s foremost medical research center, today announced that ... significant funding from the Israeli Ministry of Industry ... to support product development and advance clinical trials. ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... , GENEVA, Switzerland, May 2, 2007 – Merck,Serono ... data on,safinamide, a new agent in Phase III ... presented by Professor,Fabrizio Stocchi at the American Academy ... These data are from a,6-month (24 weeks), randomized, ...
... THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Apr 30, 2007 ... from a pivotal Phase 3,trial which ... human,monoclonal antibody directed against the epidermal ... (PFS) compared,to best supportive care (BSC) ...
Cached Medicine Technology:Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 2Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 3Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 4Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 5Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 2Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 3Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 4Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 5Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published 6
(Date:5/25/2013)... Idaho (PRWEB) May 25, 2013 A ... prevalent type of peripheral neuropathy. According to neuropathy expert ... , it is estimated that the disorder affects almost ... common complication arising from Diabetes. The high blood sugar ... Diabetes and patients suffering from it usually tend to ...
(Date:5/25/2013)... (HealthDay News) -- Many viruses and parasites that affect ... -- a bacteria-borne illness than can result in liver ... parks, according to a veterinarian. These germs ... the air, said Dr. Susan Nelson, a clinical associate ... of these serious diseases can be fatal, even with ...
(Date:5/25/2013)... 25, 2013 The report “Global ... Types, Functions, Applications, Ingredients, Shell Materials, Packaging, & ... global food encapsulation market with analysis and forecasting ... also identifies the driving and restraining factors for ... trends, opportunities, and challenges. The market is segmented ...
(Date:5/25/2013)... May 25, 2013 Studies from Johns ... are carrying excessive weight and their inability to get ... simply losing weight can naturally relieve many symptoms. ... improvement in sleep quality was significantly associated with overall ... study dated November 6th, 2012, researchers monitored ...
(Date:5/25/2013)... Sun City Center, FL (PRWEB) May 25, 2013 ... years, is one of many of the NALA’s businesses throughout ... Owner, Craig Amshel chose to participate in the nationwide event ... served as a Lieutenant Colonel in the Army. He said, ... work in the community I serve, but I live here ...
Breaking Medicine News(10 mins):Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2
... new study by the NYU Cancer Institute, an NCI-designated ... leukemia, a type of blood cancer that affects children ... an intracellular communication pathway called Notch led to the ... this disease. Notch has already been implicated in another ...
... nine-years-old can start to show an increased risk of future heart ... the May issue of Acta Paediatrica . ... studied 223 children 123 boys and 100 girls with ... over four days. They found that the children who were ...
... appears to have a genetic basis, at least in part. ... small reins) plays a key role in this process, as ... Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now shown. ... to nicotine ( Neuron , May,12, 2011, Vol. 70, Issue ...
... 12 (HealthDay News) -- Music hath charms to protect the ... Northwestern University researchers who compared adults aged 45 to 65 ... to confer advantages in at least two important functions known ... hear speech in noise," study co-author Nina Kraus, director of ...
... at the edge of an ice hole, an Antarctic emperor ... the bird descends and may not emerge again for another ... stores the blood, lungs and myoglobin in muscle ... the surface, lactate begins appearing in the penguin,s blood and ...
... a smoker,s chance of quitting, according to new research published ... This study is the first to assess the effectiveness of ... The research, which was carried out by scientists at the ... enrolled in a programme to help them quit smoking. ...
Cached Medicine News:Health News:Study reveals origins of a cancer affecting the blood and bone marrow 2Health News:Lack of exercise linked to higher heart disease risk in healthy children as young as 9 2Health News:Reining in nicotine use 2Health News:Musicians Maintain Memory, Hearing as They Age 2Health News:Penguins continue diving long after muscles run out of oxygen 2Health News:Penguins continue diving long after muscles run out of oxygen 3
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
... With the Symphony family of Pacemakers, Ela ... market. Symphony, lighter than a passport, will ... using new technologies, and delivering powerful monitoring. ... for dual-chamber and atrial tracking modes in ...
Medicine Products: